Huang J et al. |
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:24117692
|
Harb AH et al. |
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26011564
|
Miwa H et al. |
Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735925
|
Hassan C et al. |
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12969091
|
Cammarota G et al. |
High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15043520
|
Sheu BS et al. |
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15691303
|
Wong WM et al. |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16423001
|
Savarino V et al. |
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9305478
|
Zullo A et al. |
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20518756
|
Vallve M et al. |
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12030958
|